ClinicalTrials.gg
CompletedNCT04112654LoPreColUpdated Apr 9, 2024

Evaluation of the Contribution of Low-pressure Intra-abdominal Insufflation for Laparoscopic Colic Resection

An interventional study of Conventional pressure laparoscopy and Low pressure laparoscopy in Colonic Disease, sponsored by Institut Paoli-Calmettes. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by Institut Paoli-Calmettes · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The laparoscopic surgery requires gas insufflation in the peritoneal cavity and the operator chooses the intraabdominal insufflation pressure. In general, during a conventional laparoscopy, this pressure is 12 to 15 mmHg. The reduction of the intra-abdominal pressure minimizes the parietal trauma due to the insufflation and could lead to a reduction of the postoperative pains and could allow an earlier recovery. In this study, the investigator propose to evaluate the benefits of a low pressure insufflation (6-8 mmHg) with pressure-controlled insufflator in patients with a mild or malignant colon pathology requiring surgical colic resection. The main objective of the study is to demonstrate that the laparoscopic colic resection at low pressure reduces the theoretical hospital stay of one day compared to the conventional laparoscopy.

02

Conditions studied

  • Colonic Disease

Browse trials for

03

In context

Colonic Diseases

147 studies on the registry are indexed under Colonic Diseases; 23 are open to participants now.

This study's enrollment of 128 is below the median of 143 across 95 interventional studies indexed under Colonic Diseases.

Browse Colonic Diseases studies →

Lead sponsor

Institut Paoli-Calmettes is the lead sponsor of 172 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Colic lesion justifying surgical resection by segmental colectomy,
  • Surgery proposed by laparoscopy,
  • Body mass index (BMI) ≤30 kg/m2,
  • Written informed consent signed by the patient,
  • Patient affiliated to the national French statutory healthcare insurance, system or beneficiary of this regimen.

Exclusion criteria

Exclusion Criteria:

  • Probable realization of a stoma during the procedure,
  • Robot-assisted approach,
  • Contraindication to laparoscopic surgery,
  • Pregnant or likely to be pregnant,
  • Patient deprived of liberty or placed under the authority of a tutor,
  • Patient considered geographically socially or psychologically unable to comply with the study procedure and the medical follow-up.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
128 participants (actual)

Study arms

  • Active comparator
    Conventional laparoscopy

    Laparoscopy realized at the conventional pressure (12-15 mmHg) using conventional insufflator.

    Procedure: Conventional pressure laparoscopy

  • Experimental
    Low pressure laparoscopy

    Laparoscopy realized at low pressure (6-8mmHg) using pressure-controlled insufflator AirSeal®

    Procedure: Low pressure laparoscopy

Interventions

  • ProcedureConventional pressure laparoscopy

    Conventional pressure laparoscopy using conventional insufflator AirSeal®

  • ProcedureLow pressure laparoscopy

    Low pressure laparoscopy using pressure-controlled insufflator AirSeal®

06

What researchers measure

Primary outcomes

  1. The theoretical hospital stay

    The theoretical hospital stay in days (calculated from the day of the surgery to the theoretical day of discharge according to predefined exit criteria)

    Time frame: from hospitalization day until hospital discharge, assessed up to 15 days

Secondary outcomes

  1. Morbidity rate

    Morbidity evaluated according Dindo-clavien classification

    Time frame: 20 days post surgery

  2. Mortality rate

    Dead patient listing

    Time frame: 20 days post surgery

  3. GastroIntestinal-Quality-of-Life Index (GIQLI)

    GastroIntestinal-Quality-of-Life Index (GIQLI) questionnaire, 36 questions, each containing 4 answers equating to a score ranging from 0 (least desirable answer) to 4 (most desirable answer). Total score range 0-144.

    Time frame: 20 days and 3 months post surgery

  4. Short Form Health (SF12) score

    This questionnaire is an abbreviated version of the "Medical Outcomes Study Short-Form General Health Survey" (SF-36) contains only 12 items out of 36 with minimum score 0 (bad quality life) and maximum score at 100 (good quality life).

    Time frame: 20 days and 3 months post surgery

  5. Pain score using self-report pain assessment tool (EVA)

    EVA measures the intensity of pain on a scale of 0 (no pain) to 10 (maximum pain imaginable)

    Time frame: From surgery to hospital discharge assessed up to 15 days, at 20 days and at 3 months post surgery

  6. Intestinal transit recovery time frame

    Period duration from surgery to intestinal gas recovery time (in days)

    Time frame: From surgery to transit recovery assessed up to 15 days

  7. Nausea and vomiting incidence

    Nausea and vomiting listing

    Time frame: From surgery to hospital discharge assessed up to 15 days

  8. Analgesic treatment incidence

    Non-morphine and morphine analgesic consumption

    Time frame: From surgery to 3 months post surgery

  9. Real hospitalization duration

    Real hospitalization duration (actual patient discharge date based on non-medical criteria)

    Time frame: From hospitalization day until hospital discharge assessed up to 15 days

  10. Rehospitalization number

    Rehospitalization listing

    Time frame: from hospital discharge assessed up to 15 days to 3 months post surgery

  11. Differential cost of patient care

    According operating room occupation and real hospital stay

    Time frame: From surgery to hospital discharge assessed up to 15 days

07

Study locations

1 site
  • Institut Paoli Calmettes
    Marseille, Bouches Du Rhone 13009, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04112654
Responsible party
Sponsor
First posted
Oct 2, 2019
Start date
Jun 29, 2020
Primary completion
Jun 7, 2023
Completion
Oct 18, 2023
Last update
Apr 9, 2024

Study contacts

Cecile DE CHAISEMARTIN, MD
principal investigator · Institut Paoli-Calmettes

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion